USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
NANOCOR THERAPEUTICS, INC.
Address:
870 MARTIN LUTHER KING JR BLVD
CHAPEL HILL, NC 27514-2600
Phone:
N/A
URL:
N/A
EIN:
104383321
DUNS:
6064300
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $640,383.00 1

Award List:

Gene Based Therapy for Congestive Heart Failure

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$640,383.00
Agency:
HHS
Principal Investigator:
Daniel Sigg – 651-955-6502
Abstract:
DESCRIPTION (provided by applicant): Congestive heart failure is a major cause of morbidity and mortality in the United States. While progress in conventional treatments is making steady and incremental gains to reduce heart failure mortality, there is a critical need to explore new therapeutic… More